Dennis N Bourdette
Overview
Explore the profile of Dennis N Bourdette including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
68
Citations
1055
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Hartung D, Johnston K, Geddes J, Bourdette D
Neurology
. 2020 Jan;
94(13):e1407-e1414.
PMID: 31941796
Objective: To estimate changes in costs and utilization trends for disease-modifying therapies (DMTs) from 2011 to 2017 in the US Medicaid program. Methods: Using quarterly Medicaid State Drug Utilization Data...
12.
Hartung D, Alley L, Johnston K, Bourdette D
Neurology
. 2019 Nov;
94(4):e368-e375.
PMID: 31767617
Objective: To describe pricing decisions, justifications, and attitudes among current and former biotech industry executives for companies that manufacture multiple sclerosis disease-modifying therapies. Methods: Four leaders in biotech who have...
13.
Hartung D, Cohen D, Deodhar A, Bourdette D
Ann Intern Med
. 2019 Oct;
171(8):601-602.
PMID: 31610564
No abstract available.
14.
Falardeau J, Fryman A, Wanchu R, Marracci G, Mass M, Wooliscroft L, et al.
Mult Scler J Exp Transl Clin
. 2019 Jun;
5(2):2055217319850193.
PMID: 31205740
Background: Lipoic acid, an antioxidant, has beneficial effects in experimental acute optic neuritis and autoimmune encephalomyelitis. Optical coherence tomography can detect retinal nerve fiber layer thinning, representing axonal degeneration, approximately...
15.
Orban A, Garg B, Sammi M, Bourdette D, Rooney W, Kuehl K, et al.
Med Sci Sports Exerc
. 2019 Jun;
51(7):1380-1386.
PMID: 31205251
Purpose: We determined if a high-intensity aerobic exercise program would be safe, improve expected fitness and clinical outcomes, and alter exploratory phosphorous magnetic resonance spectroscopy (P MRS) outcomes in persons...
16.
Hartung D, Johnston K, Deodhar A, Bourdette D, Cohen D
Am J Kidney Dis
. 2019 Feb;
74(2):256-262.
PMID: 30765104
Despite little evidence supporting its superiority to glucocorticoid therapy, use and expenditures for repository corticotropin (rACTH) injection (H.P. Acthar Gel; Mallinckrodt) have increased dramatically in the last 5 years, particularly...
17.
Hartung D, Johnston K, Irwin A, Markwardt S, Bourdette D
Health Aff (Millwood)
. 2019 Feb;
38(2):303-312.
PMID: 30715973
The high cost of multiple sclerosis (MS) disease-modifying therapies can negatively affect access for patients through increased payer restrictions and higher out-of-pocket spending. Our objective was to describe changes in...
18.
Hartung D, Johnston K, Cohen D, Nguyen T, Deodhar A, Bourdette D
JAMA Netw Open
. 2019 Jan;
1(2):e180482.
PMID: 30646086
Importance: Despite great expense and little evidence supporting use over corticosteroids, prescriptions for repository corticotropin (H. P. Acthar Gel; Mallinckrodt Pharmaceuticals) have increased markedly. Aggressive sales tactics and payments from...
19.
Loy B, Fling B, Horak F, Bourdette D, Spain R
Complement Ther Med
. 2018 Nov;
41:169-174.
PMID: 30477834
Background: Gait and balance impairment is common in secondary progressive multiple sclerosis (SPMS). Lipoic acid (LA), an over-the-counter antioxidant, is effective in MS animal models and may improve walking speed,...
20.
Hartung D, Bourdette D, Cohen D
JAMA Intern Med
. 2018 Apr;
178(4):583-584.
PMID: 29610884
No abstract available.